Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative low-dose esketamine for postoperative pain in pediatric urologic surgery
ChiCTR2300073879Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (4 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Postoperative pain level (FLACC or NRS score). Started Jan 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300073879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073879.